Getting Started — Pharma and Alternative Treatments
Patient Selection and/or Measuring Response
We can help ensure the success of your valuable new drugs and alternative treatments through the use of our blood biomarkers. We can provide intelligence in the early stages of development about their effects, and help safeguard against complete failure in the later stages of development, if they do not meet primary endpoints. Blood samples can be analyzed and responders can be identified for subsequent more targeted clinical trials.